Growth Metrics

Bio-Techne (TECH) Net Margin (2009 - 2026)

Bio-Techne's quarterly Net Margin came in at 16.39% in Q1 2026, up 925.0% year-on-year from 1.6% in Q1 2025, and up 27.6% quarter-over-quarter from 12.85% in Q4 2025.

Bio-Techne has reported Net Margin for 18 years, with the latest figure at 16.39% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 925.0% year-over-year to 16.39%; the trailing twelve-month figure through Mar 2026 stood at 1.88% (down 479.0% YoY), and the FY2025 full-year result was 1.1%, down 1120.0% from the prior year.
  • Net Margin for Q1 2026 stood at 16.39%, up from 12.85% in the prior quarter.
  • The five-year high for Net Margin was 4486.7% in Q3 2022, with the low at 32.97% in Q2 2025.
  • Average Net Margin over 5 years is 274.57%, with a median of 15.16% recorded in 2023.
  • Year-over-year, Net Margin surged 445993 bps in 2022 and plunged 446829 bps in 2023.
  • Tracing TECH's Net Margin over 5 years: stood at 18.41% in 2022, then plunged by 45 bps to 10.08% in 2023, then rose by 17 bps to 11.75% in 2024, then advanced by 9 bps to 12.85% in 2025, then climbed by 28 bps to 16.39% in 2026.
  • The last three Net Margin figures came in at 16.39% (Q1 2026), 12.85% (Q4 2025), and 13.33% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 16.39%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.39%
Dec 31, 2025 12.85%
Sep 30, 2025 13.33%
Jun 30, 2025 -32.97%
Mar 31, 2025 7.14%
Dec 31, 2024 11.75%
Sep 30, 2024 11.61%
Jun 30, 2024 -3.42%
Mar 31, 2024 16.17%
Dec 31, 2023 10.08%
Sep 30, 2023 18.41%
Jun 30, 2023 15.16%
Mar 31, 2023 23.87%
Dec 31, 2022 18.41%
Sep 30, 2022 4,486.70%
Jun 30, 2022 21.48%
Mar 31, 2022 20.71%
Dec 31, 2021 26.76%
Sep 30, 2021 26.77%
Jun 30, 2021 -25.43%
Mar 31, 2021 18.64%
Dec 31, 2020 20.58%
Sep 30, 2020 16.35%
Jun 30, 2020 41.20%
Mar 31, 2020 18.71%
Dec 31, 2019 64.68%
Sep 30, 2019 7.86%
Jun 30, 2019 8.59%
Mar 31, 2019 24.16%
Dec 31, 2018 10.06%
Sep 30, 2018 10.68%
Jun 30, 2018 -22.11%
Mar 31, 2018 12.04%
Dec 31, 2017 31.69%
Sep 30, 2017 10.96%
Jun 30, 2017 17.63%
Mar 31, 2017 15.39%
Dec 31, 2016 5.67%
Sep 30, 2016 14.42%
Jun 30, 2016 -3.00%
Mar 31, 2016 23.13%
Dec 31, 2015 21.38%
Sep 30, 2015 20.21%
Jun 30, 2015 25.20%
Mar 31, 2015 21.28%
Dec 31, 2014 29.66%
Sep 30, 2014 22.04%
Jun 30, 2014 -109.01%
Mar 31, 2014 33.11%
Dec 31, 2013 29.82%
Sep 30, 2013 32.02%
Jun 30, 2013 82.74%
Mar 31, 2013 40.89%
Dec 31, 2012 33.78%
Sep 30, 2012 34.21%
Jun 30, 2012 34.62%
Mar 31, 2012 37.98%
Dec 31, 2011 34.57%
Sep 30, 2011 35.47%
Jun 30, 2011 -131.67%
Mar 31, 2011 40.73%
Dec 31, 2010 39.19%
Sep 30, 2010 38.82%
Jun 30, 2010 -133.99%
Mar 31, 2010 46.09%
Dec 31, 2009 37.73%
Sep 30, 2009 40.24%